Homocysteine Serum Levels as Prognostic Marker of Hepatocellular Carcinoma with Portal Vein Thrombosis.

MLA

Latteri, Saverio, et al. “Homocysteine Serum Levels as Prognostic Marker of Hepatocellular Carcinoma with Portal Vein Thrombosis.” Current Molecular Medicine, vol. 19, no. 7, 2019, pp. 532–38. EBSCOhost, https://doi.org/10.2174/1566524019666190610120416.

APA

Latteri, S., Malaguarnera, G., Catania, V. E., La Greca, G., Bertino, G., Borzì, A. M., Drago, F., & Malaguarnera, M. (2019). Homocysteine Serum Levels as Prognostic Marker of Hepatocellular Carcinoma with Portal Vein Thrombosis. Current Molecular Medicine, 19(7), 532–538. https://doi.org/10.2174/1566524019666190610120416

Chicago

Latteri, Saverio, Giulia Malaguarnera, Vito Emanuele Catania, Gaetano La Greca, Gaetano Bertino, Antonio Maria Borzì, Filippo Drago, and Michele Malaguarnera. 2019. “Homocysteine Serum Levels as Prognostic Marker of Hepatocellular Carcinoma with Portal Vein Thrombosis.” Current Molecular Medicine 19 (7): 532–38. doi:10.2174/1566524019666190610120416.